Group 1 - The company, Kehui Co., announced on November 3 that it has repurchased approximately 530,000 shares through the Shanghai Stock Exchange, accounting for 0.5095% of its total share capital of about 105 million shares [1] - The highest price for the repurchased shares was 18.52 RMB per share, while the lowest price was 13 RMB per share [1] - The total amount spent on the share repurchase was approximately 7.74 million RMB [1]

Group 1 - The company announced the completion of its share repurchase plan, having repurchased approximately 3.24 million shares, which accounts for 1.59% of the total share capital [1] - The total share capital of the company is approximately 204 million shares, with the highest transaction price being 16.88 yuan per share and the lowest at 9.93 yuan per share [1] - The total amount spent on the share repurchase is around 40 million yuan, with the repurchase period spanning from January 14, 2025, to November 3, 2025 [1]

中国核电（601985）(601985.SH)发布公告，截至2025年10月31日，公司累计回购股份数量为3126.13万 股，占公司目前总股本的比例为0.15%，购买的最高价为9.65元/股，购买的最低价为8.40元/股，已支付 的总金额为2.85亿元(不含佣金等交易费用)。 ...

海利得（002206）(002206.SZ)公告，公司截至2025年10月31日以集中竞价交易方式累计回购股份 3489.59万股，占公司目前总股本的3.00%，成交金额为1.54亿元(不含交易费用)。 ...

Group 1 - The company Sanofi Bio (300298) announced a share buyback program, having repurchased a total of 6.8275 million shares as of October 31, 2025 [1] - The repurchased shares account for 1.22% of the company's current total share capital [1] - The total amount spent on the share buyback is 139 million yuan, excluding transaction fees [1]

Group 1 - The company, New Zhonggang, announced on November 3 that it has repurchased approximately 5.68 million shares through centralized bidding, which accounts for 1.42% of the company's total share capital [1] - The highest transaction price for the repurchased shares was 8.97 CNY per share, while the lowest was 8.51 CNY per share [1] - The total amount spent on the share repurchase was approximately 49.99 million CNY [1]

Summary of Key Points Core Viewpoint - Liu Pharmaceutical Group (603368.SH) has announced a share buyback program, indicating a commitment to enhancing shareholder value through capital return strategies [1] Group 1: Buyback Details - As of October 31, 2025, the company has repurchased a total of 9.7746 million shares [1] - The repurchased shares account for 2.46% of the company's total share capital, an increase of 0.42% compared to the previous announcement [1] - The highest price paid for the shares was 19.07 yuan per share, while the lowest price was 17.83 yuan per share [1] - The total amount spent on the buyback is 180 million yuan, excluding transaction fees [1]

Summary of Key Points Core Viewpoint - The company, Nanbo A (000012.SZ), has announced a share repurchase plan, indicating a commitment to returning value to shareholders through the buyback of both A-shares and B-shares, totaling 2.1307% of the company's total equity [1]. Group 1: A-Shares Repurchase - The company has repurchased a total of 38.191671 million A-shares [1]. - The highest transaction price for A-shares was 5.04 CNY per share, while the lowest was 4.54 CNY per share [1]. - The total amount spent on repurchasing A-shares was 181 million CNY, excluding transaction fees [1]. Group 2: B-Shares Repurchase - The company has repurchased a total of 27.234696 million B-shares [1]. - The highest transaction price for B-shares was 1.94 HKD per share, and the lowest was 1.65 HKD per share [1]. - The total amount spent on repurchasing B-shares was 49.1815 million HKD [1].

Core Viewpoint - The company, Haizheng Pharmaceutical, announced its fourth share repurchase plan, which will commence on May 12, 2025, and is expected to last until May 11, 2026, with a budget of 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] Summary by Categories Share Repurchase Plan - The company plans to repurchase shares through centralized bidding, with a total expected amount of 50 million to 100 million yuan [1] - The repurchase period is set from May 12, 2025, to May 11, 2026 [1] Current Repurchase Status - As of the end of October 2025, the company has repurchased a total of 6,115,000 shares, which accounts for 0.51% of the total share capital [1] - The total amount spent on repurchases so far is 56.9915 million yuan, with repurchase prices ranging from 8.92 yuan to 10.55 yuan per share [1]

Core Viewpoint - The company, Nengte Technology (002102.SZ), has announced a share buyback program, having repurchased a total of 34.2361 million shares, which represents 1.38% of its total share capital, with a total transaction amount of 140 million yuan (excluding transaction fees) [1] Summary by Categories Share Buyback - The company has completed a cumulative buyback of 34.2361 million shares as of October 31, 2025 [1] - This buyback accounts for 1.38% of the company's total share capital [1] - The total amount spent on the buyback is 140 million yuan, excluding transaction fees [1]